Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults
- 8 March 2007
- Vol. 25 (12) , 2288-2295
- https://doi.org/10.1016/j.vaccine.2006.11.065
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparityVaccine, 2005
- Pneumococcal vaccination in the emergency department: An assessment of needAnnals of Emergency Medicine, 2004
- Epidemiology of Invasive Streptococcus pneumoniae among Navajo Children in the Era before Use of Conjugate Pneumococcal Vaccines, 1989-1996American Journal of Epidemiology, 2004
- Invasive Pneumococcal Disease among Navajo Adults, 1989–1998Clinical Infectious Diseases, 2004
- Effectiveness of the 23‐Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo AdultsThe Journal of Infectious Diseases, 2003
- A systematic approach for increasing pneumococcal vaccination rates at an inner-city public hospitalAmerican Journal of Preventive Medicine, 2002
- Serotype Distribution and Antimicrobial Resistance Patterns of Invasive Isolates ofStreptococcus pneumoniae:Alaska, 1991–1998The Journal of Infectious Diseases, 2000
- The Epidemiology of Invasive Pneumococcal Disease in Alaska, 1986-1990 Ethnic Differences and Opportunities for PreventionThe Journal of Infectious Diseases, 1994
- Alcohol abuse among Native AmericansJournal of Community Health, 1988
- Pneumococcal Disease after Pneumococcal VaccinationNew England Journal of Medicine, 1980